Pfizer (PFE)

Income Tax Expense

-$164.00M

TTM · Period ending: · USD

PFE logo

PFE Income Tax Expense

Latest reported-$164.00M
PFE Income Tax ($296.40M → -$164.00M)
High-resolution chart · PNG

PFE income tax expense history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Pfizer Income Tax Expense — Annual fiscal periods (USD)
Period endingIncome Tax Expense (USD)
-266,000,000
-28,000,000
-1,114,000,000
3,328,000,000
1,852,000,000
370,000,000
618,000,000
706,000,000
-9,048,000,000
1,122,000,000
1,990,000,000
3,121,000,000
4,306,000,000
2,221,000,000
3,621,000,000
1,071,000,000
2,197,000,000
1,645,000,000
1,023,000,000
1,992,000,000
3,178,000,000
2,665,000,000
1,621,000,000
2,609,000,000
2,561,000,000
2,049,000,000
1,244,000,000
-642,000,000
865,000,000
869,000,000
738,000,000
558,500,000
191,300,000
438,600,000
218,400,000
297,900,000
231,300,000
309,400,000
317,300,000
300,700,000
296,400,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.